// App-Quantinova.ai

53 : Ex-Vivo Perfusion Mediated Delivery of Rituximab to Clear Latent Epstein-Barr Virus

Researchers

Presenter

  • T. Ku

Principal Investigators

  • M. Cypel

  • R. V. Ribeiro

  • V. H. Ferreira

  • D. Kumar

  • A. Humar

Medical Centers

  • Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • B-lymphocyte antigen CD20

  • Cluster of Differentiation 19

  • Interleukin-8

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved